We are very excited to announce the Twitter account of the Hematology/Oncology fellowship program RUSH Cancer Center! We will be posting program highlights, events, tweetorials, and updates on our current and former fellows! Rush University System for Health #MedEd #Hematology #Oncology

Over her lifetime, a woman in the United States has about a one in eight chance of developing breast cancer. Rush medical oncologist Ruta Rao, MD, shares five important facts that every woman needs to know. rsh.md/32XJmZK

First day of Heme Onc fellowship interviews today. Excited to meet our potential future fellows! RUSH Heme/Onc RUSH Cancer Center

Great advice on recommending vaccination for our immunocompromised patients despite them not being able to amount a great immune response. “Some degree of immunity is better than no degree.” Thank you Dr. Fauci for your leadership and inspiring all of us. AnthonyFauci #ASH20

Rush fellows at #ASCO22 post plenary session. So much exciting data!

After a long queue after FDA approval, Our first patient on Lu177 PSMA 617 for mCRPC RUSH Cancer Center just sent me this nice message after first dose. Clearly a game changer. @revkolli RUSH Heme/Onc

Another triple therapy to choose from in mHSPC! PEACE-1 or ARASENS Revathi Kollipara Ami Dave Taha Alrifai How will you choose? RUSH Heme/Onc

Great multi disciplinary case-based presentation at today’s medical grand rounds of a patient with HIV+/HHV8+ multicentric Castleman disease who presented with fevers and AMS, thrombocytopenia, diffuse LAD, and ARF. Amazing recovery of plt count with weekly rituximab.

Very relevant discussion which just had this morning with 79 year old with T3a RCC as he goes home to ponder our discussion. Revathi Kollipara RUSH Heme/Onc

Team Rush at the Leukemia & Lymphoma Society’s Light the Night! Great night honoring and supporting patients with blood cancers. @ Soldier Field instagram.com/p/CkCdCXsuZvV/…

Poster K10: In advanced stage #RCC: detectable #ctDNA showed a 90.9% concordance with progression (20/22); undetectable ctDNA showed an 83.3% concordance. Non-clear cell sheds significantly more. Proud of RISING STAR Revathi Kollipara Arnab Basu RUSH Heme/Onc Rush University System for Health #GU23

So grateful to have the best mentor! #ASCO23